The seminar is devoted to practical issues of demonstrating the bioequivalence of medicinal products through the biowaiver procedure based on the biopharmaceutics classification system (BCS). The focus is on the requirements of the guideline ICH M9 Guideline on biopharmaceutics classification system-based biowaivers.
Organizers: the Agency for Methodological and Scientific-Practical Work in cooperation with specialists of the Center’s Department for Bioavailability and Equivalence Assessment.
Seminar speakers: Nadiia Zhukova – Director of the Department of Bioavailability and Equivalence Assessment, Oksana Nahorniak, Head of the Bioavailability Materials Assessment Division.
In the programme
- The concept of bioequivalence and approaches to demonstrating it depending on the dosage form
- Updated requirements for proof of bioequivalence by biowaiver based on the BCS (ICH M9, ST-N MOZU 42-7.5:2023)
- Selection and justification of the reference product
- Updated requirements for determining the solubility of the active substance according to the BCS (WHO)
- Specifics of preparing bioavailability materials (absolute bioavailability, mass balance, Caco 2)
- Updated requirements for excipients
- Recommendations on preparing reports, typical errors
- and other issues.
PROGRAM
Invited to participate: applicants, medicinal product developers, researchers, managers of medicinal product development project management, innovation specialists, and all interested parties.
Format: Offline
Certificate: each seminar participant will receive a certificate
Presentation and information materials: available during the event
Registration: to participate, fill in the Application and send it electronically in doc / docx format to amsw@dec.gov.ua
Contact person: Svitlana Borodai
tel.: +38 (044) 202-17-00 (2251)
e-mail: borodai@dec.gov.ua
For more information about training at the Center, see the Plan of External Training Events of the Center and book dates in advance.
We look forward to your participation!